128 related articles for article (PubMed ID: 7586963)
1. Current usage of contrast agents, anticoagulant and antiplatelet drugs in angiography and angioplasty in the UK.
Jackson DM; Dawson P
Clin Radiol; 1995 Oct; 50(10):699-704. PubMed ID: 7586963
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics and UK usage of heparin in vascular intervention.
Zaman SM; de Vroos Meiring P; Gandhi MR; Gaines PA
Clin Radiol; 1996 Feb; 51(2):113-6. PubMed ID: 8631163
[TBL] [Abstract][Full Text] [Related]
3. Corticosteroid prophylaxis for patients with increased risk of adverse reactions to intravascular contrast agents: a survey of current practice in the UK.
Seymour R; Halpin SF; Hardman JA; Coote JM; Ruttley MS; Roberts GM
Clin Radiol; 1994 Nov; 49(11):791-5. PubMed ID: 7955846
[TBL] [Abstract][Full Text] [Related]
4. [Current patterns of the use of heparin in angiography].
Miller DL
J Radiol; 1990 Mar; 71(3):151-7. PubMed ID: 2191118
[TBL] [Abstract][Full Text] [Related]
5. High dose bolus heparin as initial therapy before primary angioplasty for acute myocardial infarction: results of the Heparin in Early Patency (HEAP) pilot study.
Verheugt FW; Liem A; Zijlstra F; Marsh RC; Veen G; Bronzwaer JG
J Am Coll Cardiol; 1998 Feb; 31(2):289-93. PubMed ID: 9462569
[TBL] [Abstract][Full Text] [Related]
6. Relationship of anticoagulation and radiographic contrast agents to thrombosis during coronary angiography and angioplasty: are there real concerns?
Hill JA; Grabowski EF
Cathet Cardiovasc Diagn; 1992 Mar; 25(3):200-8. PubMed ID: 1571975
[TBL] [Abstract][Full Text] [Related]
7. Heparin in angiography: current patterns of use.
Miller DL
Radiology; 1989 Sep; 172(3 Pt 2):1007-11. PubMed ID: 2672098
[TBL] [Abstract][Full Text] [Related]
8. [ANMCO/SIC/SICI-GISE/SICCH Consensus document: Clinical approach to pharmacological pretreatment for patients undergoing myocardial revascularization].
Caporale R; Geraci G; Gulizia MM; Borzi M; Colivicchi F; Menozzi A; Musumeci G; Scherillo M; Ledda A; Tarantini G; Gerometta P; Casolo G; Formigli D; Romeo F; Di Bartolomeo R;
G Ital Cardiol (Rome); 2016 Jun; 17(6):462-90. PubMed ID: 27311089
[TBL] [Abstract][Full Text] [Related]
9. Current practice in the use of antiplatelet agents in the peri-operative period by UK vascular surgeons.
Smout J; Stansby G
Ann R Coll Surg Engl; 2003 Mar; 85(2):97-101. PubMed ID: 12648338
[TBL] [Abstract][Full Text] [Related]
10. [Effect of various contrast media on platelet aggregation--an in vivo study].
Shinmoto H; Ido K; Yuasa Y; Endo M; Yasuoka H; Edamitsu S; Takahashi K; Koizumi J; Hiramatsu K
Nihon Igaku Hoshasen Gakkai Zasshi; 1989 Feb; 49(2):163-7. PubMed ID: 2755782
[TBL] [Abstract][Full Text] [Related]
11. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
12. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
[TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty.
Kereiakes DJ; Kleiman NS; Ambrose J; Cohen M; Rodriguez S; Palabrica T; Herrmann HC; Sutton JM; Weaver WD; McKee DB; Fitzpatrick V; Sax FL
J Am Coll Cardiol; 1996 Mar; 27(3):536-42. PubMed ID: 8606262
[TBL] [Abstract][Full Text] [Related]
14. OPCAB therapy survey: off-pump clopidogrel, aspirin or both therapy survey.
D'Ancona G; Donias HW; Karamanoukian RL; Bergsland J; Karamanoukian HL
Heart Surg Forum; 2001; 4(4):354-8. PubMed ID: 11803149
[TBL] [Abstract][Full Text] [Related]
15. Optimizing heparin utilization in angiographic flush solutions.
Glickstein MF; McLean GK; Sussman SK
Angiology; 1990 Oct; 41(10):825-8. PubMed ID: 2221461
[TBL] [Abstract][Full Text] [Related]
16. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
Mehran R; Nikolsky E; Kirtane AJ; Caixeta A; Wong SC; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Kim YH; Fahy M; Dangas GD
JACC Cardiovasc Interv; 2009 May; 2(5):415-21. PubMed ID: 19463464
[TBL] [Abstract][Full Text] [Related]
17. Laboratory monitoring of heparin and the combination of heparin and the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3) in patients undergoing percutaneous transluminal coronary angioplasty (PTCA).
Zahn R; Haubelt H; Bechtloff S; Schneider S; Frilling B; Rustige J; Marsalek P; Seidl K; Senges J; Hellstern P
Herz; 2003 Aug; 28(5):445-52. PubMed ID: 12928744
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation and antiplatelet therapy in urological practice: ICUD/AUA review paper.
Culkin DJ; Exaire EJ; Green D; Soloway MS; Gross AJ; Desai MR; White JR; Lightner DJ
J Urol; 2014 Oct; 192(4):1026-34. PubMed ID: 24859439
[TBL] [Abstract][Full Text] [Related]
19. Systemic platelet effects of contrast media: implications for cardiologic research and clinical practice.
Dalby MC; Davidson SJ; Burman JF; Clague J; Sigwart U; Davies SW
Am Heart J; 2002 Jan; 143(1):E1. PubMed ID: 11773932
[TBL] [Abstract][Full Text] [Related]
20. Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial.
Kastrati A; Schühlen H; Hausleiter J; Walter H; Zitzmann-Roth E; Hadamitzky M; Elezi S; Ulm K; Dirschinger J; Neumann FJ; Schömig A
Circulation; 1997 Jul; 96(2):462-7. PubMed ID: 9244213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
